Stock info Gimv | Filter  Basic-Info

GIMV is a multinational a private equity and venture capital corporation that deals with direct and fund of funds investments. GIMV NV was established on February 25, 1980 and its headquarters is located in Antwerp, Belgium with other offices across Europe. As far as direct investments are considered, the corporation focuses on buyouts, shareholder loans, startups, public to private transactions, replacement capital, bridge financing, recapitalization, SME etc. and PIPES. The company also looks forward to make an investment in venture capital and private equity funds. Company search for high performance growth businesses to spend in that act in response to & are able to accelerate their internal growth through mergers & acquisitions.

The company usually invests in consumer, health and care together with pioneering life science study, modern medical technology, Biopharma, and groundbreaking concepts and business models in the broader health and care business which also consists of supplier of smart systems and services, sustainable cities as well as services, utilities, physical and digital infrastructure and clean technology.

GIMV chooses to make investments in marketing, retail, communication services businesses, information and communication technologies, pharmaceutical R&D, green energy, ecological technologies, biotechnology, processing food and related divisions. The Corporation generally focuses on the European market and mid cap businesses in Brussels, and also had some investments in Kazakhstan, Italy, Luxembourg, UK, Czech Republic, and Slovakia. For fund of fund investments, company's major area of investment is in Europe. GIMV is looking forward to invest roughly around $ 425 million in companies with high enterprise value and sales value ranging to $567 million. The company invests in the form of equity and mezzanine. The GIMV group invests in small to mid-sized well-known businesses having their operations in Belgium, France, Germany, and the Netherlands. The company also invests in Central Europe and Russia via affiliates and joint ventures.

Moreover, the company always plans to have an exit in terms of investments within 4-6 years. Within the venture capital, the group focuses on early and late phase investments in software & internet, Biopharma, farming, clean and medical technology businesses based in Europe, France, and the United States. The corporation readily invests between $736.33 million to $36.82 million per company. The GIMV group desires to take a major position in its portfolio companies. It concentrates on investments in companies based in Europe. In clean technology, the firm desire to invest in a new type of energy together with renewable energy, energy conversion; pioneering materials to develop operational performance and efficiency while minimizing costs and energy consumption
For growth capital investments, the company desires to uphold a minority stake in its portfolio companies.